Characterization of immune-related alternative polyadenylation events in cancer immunotherapy.
Cancer Res. 2022 Aug 5:CAN-22-1417. doi: 10.1158/0008-5472.CAN-22-1417. Online ahead of print.
Cancer Res. 2022.
PMID: 35930727